News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Vaddi Krishna
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/26/2023 |
4
| Vaddi Krishna (CEO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Bought 1,000 shares
@ $5.0114, valued at
$5k
Bought 900 shares
@ $5.31, valued at
$4.8k
|
|
| 05/25/2023 |
4
| Vaddi Krishna (CEO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Bought 11,856 shares
@ $5.63, valued at
$66.7k
|
|
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
4
| Vaddi Krishna (CEO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 330,000 options to buy
@ $7.2, valued at
$2.4M
|
|
| 12/21/2022 |
4
| Vaddi Krishna (CEO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Bought 19,188 shares
@ $5.1306, valued at
$98.4k
|
|
| 02/17/2022 |
4
| Vaddi Krishna (CEO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 327,900 options to buy
@ $10.58, valued at
$3.5M
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
SC 13G
| Vaddi Krishna reports a 12.6% stake in Prelude Therapeutics Incorporated |
| 09/29/2020 |
4
| Vaddi Krishna (President, CEO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Converted 101,477 shares
@ $0
Converted 32,876 shares
@ $0
Converted 32,876 shares
@ $0
Converted 101,477 preferred shares
@ $0
Converted 32,876 preferred shares
@ $0
Converted 32,876 preferred shares
@ $0 |
|
| 09/24/2020 |
3
| Vaddi Krishna (President, CEO) has filed a Form 3 on Prelude Therapeutics Inc |
|
|